Two Oral Cancer Drugs Effective in ‘Steve Jobs’ Disease (CME/CE)
(MedPage Today) — Two small-molecule kinase inhibitors appear to be effective at extending progression-free survival in pancreatic neuroendocrine tumors, researchers say.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com